Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 10, 2009, Pages 1846-1854

  Zorzano, Antonio ^a,b,c   Liesa, Marc ^a,b,c   Palacín, Manuel ^a,b,c  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Insulin resistance; Mitochondria; Mitofusin; Obesity; Type 2 diabetes

Indexed keywords

HYBRID PROTEIN; INSULIN; MITOCHONDRIAL PROTEIN; MITOFUSIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA;

CELL METABOLISM; CYTOSKELETON; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; INSULIN RESISTANCE; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OBESITY;

MAMMALIA;

EID: 68949116271     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.02.004     Document Type: Review

References (106)

1. Amchenkova A.A., Bakeeva L.E., Chentsov Y.S., Skulachev V.P., and Zorov D.B. Coupling membranes as energy-transmitting cables. I. Filamentous mitochondria in fibroblasts and mitochondrial clusters in cardiomyocytes. J Cell Biol 107 (1988) 481-495
2. Arany Z., Lebrasseur N., Morris C., Smith E., Yang W., Ma Y., et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 5 (2007) 35-46
3. Bach D., Naon D., Pich S., Soriano F.X., Vega N., Rieusset J., et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 54 (2005) 2685-2693
4. Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278 (2003) 17190-17197
5. Bakeeva L.E., Chentsov Y.S., and Skulachev V.P. Mitochondrial framework (reticulum mitochondriale) in rat diaphragm muscle. Biochim Biophys Acta 501 (1978) 349-369
6. Bakeeva L.E., Chentsov Y.S., and Skulachev V.P. Ontogenesis of mitochondrial reticulum in rat diaphragm muscle. Eur J Cell Biol 25 (1981) 175-181
7. Barroso I., Luan J., Sandhu M.S., Franks P.W., Crowley V., Schafer A.J., et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49 (2006) 501-505
8. Bereiter-Hahn J., and Voth M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 27 (1994) 198-219
9. Boirie Y., Short K.R., Ahlman B., Charlton M., and Nair K.S. Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 50 (2001) 2652-2658
10. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.A., Morio B., et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118 (2008) 789-800
11. Boss O., Bachman E., Vidal-Puig A., Zhang C.Y., Peroni O., and Lowell B.B. Role of the beta(3)-adrenergic receptor and/or a putative beta(4)-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-gamma coactivator-1. Biochem Biophys Res Commun 261 (1999) 870-876
12. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsoe R., and Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50 (2007) 790-796
13. Cartoni R., Leger B., Hock M.B., Praz M., Crettenand A., Pich S., et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol 567 (2005) 349-358
14. Chen H., Chomyn A., and Chan D.C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280 (2005) 26185-26192
15. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., and Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160 (2003) 189-200
16. Cipolat S., Rudka T., Hartmann D., Costa V., Serneels L., Craessaerts K., et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126 (2006) 163-175
17. Cogswell A.M., Stevens R.J., and Hood D.A. Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am J Physiol 264 (1993) C383-C389
18. Consoli A., Nurjhan N., Reilly Jr. J.J., Bier D.M., and Gerich J.E. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest 86 (1990) 2038-2045
19. Cortese J.D. Stimulation of rat liver mitochondrial fusion by an outer membrane-derived aluminum fluoride-sensitive protein fraction. Exp Cell Res 240 (1998) 122-133
20. Cusi K., Consoli A., and DeFronzo R.A. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81 (1996) 4059-4067
21. Ek J., Andersen G., Urhammer S.A., Gaede P.H., Drivsholm T., Borch-Johnsen K., et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44 (2001) 2220-2226
22. Fawcett K.A., Wareham N.J., Luan J., Syddall H., Cooper C., O'Rahilly S., et al. PARL Leu262Val is not associated with fasting insulin levels in UK populations. Diabetologia 49 (2006) 2649-2652
23. Felber J.P., Ferrannini E., Golay A., Meyer H.U., Theibaud D., Curchod B., et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36 (1987) 1341-1350
24. Frezza C., Cipolat S., Martins d.B., Micaroni M., Beznoussenko G.V., Rudka T., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126 (2006) 177-189
25. Gastaldi G., Russell A., Golay A., Giacobino J.P., Habicht F., Barthassat V., et al. Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia 50 (2007) 2348-2355
26. Griparic L., van der Wel N.N., Orozco I.J., Peters P.J., and van der Bliek A.M. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 279 (2004) 18792-18798
27. Guillery O., Malka F., Landes T., Guillou E., Blackstone C., Lombes A., et al. Metalloprotease-mediated OPA1 processing is modulated by the mitochondrial membrane potential. Biol Cell 100 (2008) 315-325
28. Halvatsiotis P., Short K.R., Bigelow M., and Nair K.S. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 51 (2002) 2395-2404
29. Handschin C., Choi C.S., Chin S., Kim S., Kawamori D., Kurpad A.J., et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest 117 (2007) 3463-3474
30. Hara K., Tobe K., Okada T., Kadowaki H., Akanuma Y., Ito C., et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia 45 (2002) 740-743
31. Ishihara N., Fujita Y., Oka T., and Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 25 (2006) 2966-2977
32. James D.I., Parone P.A., Mattenberger Y., and Martinou J.C. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 278 (2003) 36373-36379
33. Jofuku A., Ishihara N., and Mihara K. Analysis of functional domains of rat mitochondrial Fis1, the mitochondrial fission-stimulating protein. Biochem Biophys Res Commun 333 (2005) 650-659
34. Joshi R.L., Lamothe B., Cordonnier N., Mesbah K., Monthioux E., Jami J., et al. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15 (1996) 1542-1547
35. Kelley D.E., Goodpaster B., Wing R.R., and Simoneau J.A. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277 (1999) E1130-E1141
36. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
37. Kelley D.E., and Mandarino L.J. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49 (2000) 677-683
38. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes 51 (2002) 2944-2950
39. Kitamura T., Kitamura Y., Nakae J., Giordano A., Cinti S., Kahn C.R., et al. Mosaic analysis of insulin receptor function. J Clin Invest 113 (2004) 209-219
40. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7 (2008) 45-56
41. Kraft C.S., LeMoine C.M., Lyons C.N., Michaud D., Mueller C.R., and Moyes C.D. Control of mitochondrial biogenesis during myogenesis. Am J Physiol Cell Physiol 290 (2006) C1119-C1127
42. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309 (2005) 481-484
43. Legros F., Lombes A., Frachon P., and Rojo M. Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell 13 (2002) 4343-4354
44. Lelliott C.J., Ljungberg A., Ahnmark A., William-Olsson L., Ekroos K., Elmgren A., et al. Hepatic PGC-1{beta} overexpression induces combined hyperlipidemia and modulates the response to PPAR{alpha} activation. Arterioscler Thromb Vasc Biol (2007)
45. Lelliott C.J., Medina-Gomez G., Petrovic N., Kis A., Feldmann H.M., Bjursell M., et al. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 4 (2006) e369
46. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3 (2005) e101
47. Lewis M.R., and Lewis W.H. Mitochondria in tissue culture. Science 39 (1914) 330-333
48. Liesa M., Borda-d'Agua B., Medina-Gomez G., Lelliott C.J., Paz J.C., Rojo M., et al. Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS ONE 3 (2008) e3613
49. Lin J., Puigserver P., Donovan J., Tarr P., and Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 277 (2002) 1645-1648
50. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St Pierre J., Zhang C.Y., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119 (2004) 121-135
51. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120 (2005) 261-273
52. Malka F., Guillery O., Cifuentes-Diaz C., Guillou E., Belenguer P., Lombes A., et al. Separate fusion of outer and inner mitochondrial membranes. EMBO Rep 6 (2005) 853-859
53. Meeusen S., McCaffery J.M., and Nunnari J. Mitochondrial fusion intermediates revealed in vitro. Science 305 (2004) 1747-1752
54. Meirhaeghe A., Crowley V., Lenaghan C., Lelliott C., Green K., Stewart A., et al. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 373 (2003) 155-165
55. Menshikova E.V., Ritov V.B., Ferrell R.E., Azuma K., Goodpaster B.H., and Kelley D.E. Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol 103 (2007) 21-27
56. Menshikova E.V., Ritov V.B., Toledo F.G., Ferrell R.E., Goodpaster B.H., and Kelley D.E. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288 (2005) E818-E825
57. Mingrone G., Manco M., Calvani M., Castagneto M., Naon D., and Zorzano A. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?. Diabetologia 48 (2005) 2108-2114
58. Mogensen M., Sahlin K., Fernstrom M., Glintborg D., Vind B.F., Beck-Nielsen H., et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56 (2007) 1592-1599
59. Mootha V.K., Handschin C., Arlow D., Xie X., St Pierre J., Sihag S., et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 101 (2004) 6570-6575
60. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34 (2003) 267-273
61. Morino K., Petersen K.F., Dufour S., Befroy D., Frattini J., Shatzkes N., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115 (2005) 3587-3593
62. Nair K.S., Bigelow M.L., Asmann Y.W., Chow L.S., Coenen-Schimke J.M., Klaus K.A., et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57 (2008) 1166-1175
63. Nunnari J., Marshall W.F., Straight A., Murray A., Sedat J.W., and Walter P. Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell 8 (1997) 1233-1242
64. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100 (2003) 8466-8471
65. Pawlikowska P., Gajkowska B., Hocquette J.F., and Orzechowski A. Not only insulin stimulates mitochondriogenesis in muscle cells, but mitochondria are also essential for insulin-mediated myogenesis. Cell Prolif 39 (2006) 127-145
66. Pawlikowska P., Gajkowska B., and Orzechowski A. Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro. Cell Tissue Res 327 (2007) 571-581
67. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
68. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New Eng J Med 350 (2004) 664-671
69. Pich S., Bach D., Briones P., Liesa M., Camps M., Testar X., et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 14 (2005) 1405-1415
70. Pilegaard H., Saltin B., and Neufer P.D. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546 (2003) 851-858
71. Pospisilik J.A., Knauf C., Joza N., Benit P., Orthofer M., Cani P.D., et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131 (2007) 476-491
72. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., and Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 (1998) 829-839
73. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., and Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54 (2005) 8-14
74. Santel A., Frank S., Gaume B., Herrler M., Youle R.J., and Fuller M.T. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 116 (2003) 2763-2774
75. Santel A., and Fuller M.T. Control of mitochondrial morphology by a human mitofusin. J Cell Sci 114 (2001) 867-874
76. Schrauwen-Hinderling V.B., Mensink M., Hesselink M.K., Sels J.P., Kooi M.E., and Schrauwen P. The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function. J Clin Endocrinol Metab 93 (2008) 2917-2921
77. Schuler M., Ali F., Chambon C., Duteil D., Bornert J.M., Tardivel A., et al. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4 (2006) 407-414
78. Skulachev V.P. Mitochondrial filaments and clusters as intracellular power-transmitting cables. Trends Biochem Sci 26 (2001) 23-29
79. Smirnova E., Shurland D.L., Ryazantsev S.N., and van der Bliek A.M. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 143 (1998) 351-358
80. Song Z., Chen H., Fiket M., Alexander C., and Chan D.C. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 178 (2007) 749-755
81. Sonoda J., Mehl I.R., Chong L.W., Nofsinger R.R., and Evans R.M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA 104 (2007) 5223-5228
82. Soriano F.X., Liesa M., Bach D., Chan D.C., Palacin M., and Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 55 (2006) 1783-1791
83. St Pierre J., Lin J., Krauss S., Tarr P.T., Yang R., Newgard C.B., et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278 (2003) 26597-26603
84. Stacpoole P.W., and Greene Y.J. Dichloroacetate. Diab Care 15 (1992) 785-791
85. Stacpoole P.W., Moore G.W., and Kornhauser D.M. Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med 298 (1978) 526-530
86. Storlien L., Oakes N.D., and Kelley D.E. Metabolic flexibility. Proc Nutr Soc 63 (2004) 363-368
87. Stump C.S., Short K.R., Bigelow M.L., Schimke J.M., and Nair K.S. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100 (2003) 7996-8001
88. Thomas D.Y., and Wilkie D. Recombination of mitochondrial drug-resistance factors in Saccharomyces cerevisiae. Biochem Biophys Res Commun 30 (1968) 368-372
89. Toledo F.G., Menshikova E.V., Azuma K., Radikova Z., Kelley C.A., Ritov V.B., et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 57 (2008) 987-994
90. Toledo F.G., Menshikova E.V., Ritov V.B., Azuma K., Radikova Z., DeLany J., et al. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56 (2007) 2142-2147
91. Toledo F.G., Watkins S., and Kelley D.E. Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women. J Clin Endocrinol Metab 91 (2006) 3224-3227
92. Tondera D., Czauderna F., Paulick K., Schwarzer R., Kaufmann J., and Santel A. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J Cell Sci 118 (2005) 3049-3059
93. Tondera D., Santel A., Schwarzer R., Dames S., Giese K., Klippel A., et al. Knockdown of MTP18, a novel phosphatidylinositol 3-kinase-dependent protein, affects mitochondrial morphology and induces apoptosis. J Biol Chem 279 (2004) 31544-31555
94. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429 (2004) 417-423
95. Twig G., Graf S.A., Wikstrom J.D., Mohamed H., Haigh S.E., Elorza A., et al. Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP. Am J Physiol Cell Physiol 291 (2006) C176-C184
96. Vianna C.R., Huntgeburth M., Coppari R., Choi C.S., Lin J., Krauss S., et al. Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance. Cell Metab 4 (2006) 453-464
97. Wakabayashi T., Asano M., and Kurono C. Mechanism of the formation of megamitochondria induced by copper-chelating agents. I. On the formation process of megamitochondria in cuprizone-treated mouse liver. Acta Pathol Jpn 25 (1975) 15-37
98. Wakabayashi T., and Green D.E. Membrane fusion in mitochondria. I. Ultrastructural basis for fusion. J Electron Microsc (Tokyo) 26 (1977) 305-320
99. Walder K., Kerr-Bayles L., Civitarese A., Jowett J., Curran J., Elliott K., et al. The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes. Diabetologia 48 (2005) 459-468
100. Wang Y.X., Zhang C.L., Yu R.T., Cho H.K., Nelson M.C., Bayuga-Ocampo C.R., et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2 (2004) e294
101. Wasiak S., Zunino R., and McBride H.M. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 177 (2007) 439-450
102. Wredenberg A., Freyer C., Sandstrom M.E., Katz A., Wibom R., Westerblad H., et al. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun 350 (2006) 202-207
103. Yaffe M.P. The machinery of mitochondrial inheritance and behavior. Science 283 (1999) 1493-1497
104. Yoon Y., Krueger E.W., Oswald B.J., and McNiven M.A. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 23 (2003) 5409-5420
105. Yoon Y., Pitts K.R., Dahan S., and McNiven M.A. A novel dynamin-like protein associates with cytoplasmic vesicles and tubules of the endoplasmic reticulum in mammalian cells. J Cell Biol 140 (1998) 779-793
106. Zhang D., Liu Z.X., Choi C.S., Tian L., Kibbey R., Dong J., et al. Mitochondrial dysfunction due to long-chain acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA 104 (2007) 17075-17080